Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Noguchi K et al. The detection of platelet-activating factor in inflamed human gingival tissue. 1989 Arch. Oral Biol. pmid:2783040
Feliste R et al. Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta. 1989 Atherosclerosis pmid:2783199
Inoue T and Kannan MS Platelet-activating factor-induced functional changes in the guinea pig trachea in vitro. 1989 Respir Physiol pmid:2781159
Senn N and Garay RP Regulation of Na+ and K+ contents in rat thymocytes. 1989 Am. J. Physiol. pmid:2546433
Cirino G et al. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. 1989 Proc. Natl. Acad. Sci. U.S.A. pmid:2470103
Bregestovski PD and Ryan US Voltage-gated and receptor-mediated ionic currents in the membrane of endothelial cells. 1989 J. Mol. Cell. Cardiol. pmid:2471836
Morimoto H et al. Plasma extravasation by chemical mediators in rat skin and trachea: a role of neurogenic agents on tracheal edema formation. 1989 Jpn. J. Pharmacol. pmid:2473234
Baydoun AR et al. Effects of endothelin-1 on the rat isolated heart. 1989 J. Cardiovasc. Pharmacol. pmid:2473308
Mencia-Huerta JM et al. Acute and long-term pulmonary effects of platelet-activating factor. 1989 Clin. Exp. Allergy pmid:2473829
Dray F et al. Prostaglandin E2, leukotriene C4, and platelet-activating factor receptor sites in the brain. Binding parameters and pharmacological studies. 1989 Ann. N. Y. Acad. Sci. pmid:2549827
Hosford D et al. Platelet-activating factor and cytokine interactions in shock. 1989 Resuscitation pmid:2555874
Yoshida N et al. Pathogenesis of platelet-activating factor-induced gastric mucosal damage in rats. 1989 Scand. J. Gastroenterol. Suppl. pmid:2556790
Block LH et al. Platelet-activating factor (PAF)-dependent biochemical, morphologic, and physiologic responses of human platelets: demonstration of translocation of protein kinase C associated with protein phosphorylation. 1989 Am. J. Respir. Cell Mol. Biol. pmid:2624764
Murphy S and Welk G Arachidonic acid evokes inositol phospholipid hydrolysis in astrocytes. 1989 FEBS Lett. pmid:2509246
Griswold DE et al. Absence of a lyso-PAF relationship with PAF (platelet activating factor) in monosodium urate crystal-induced inflammatory exudates. 1989 Eicosanoids pmid:2629894
Spangenberg P et al. Blood platelet behaviour in patients with a type I diabetes mellitus. 1989 Exp. Clin. Endocrinol. pmid:2630313
Medeiros YS and Calixto JB Effect of PAF-acether on the reactivity of the isolated rat myometrium. 1989 Braz. J. Med. Biol. Res. pmid:2636008
Jancar S et al. Paf-induced release of spasmogens from guinea-pig lungs. 1989 Br. J. Pharmacol. pmid:2538179
Kajiyama Y et al. Pertussis toxin-sensitive GTP-binding proteins may regulate phospholipase A2 in response to thrombin in rabbit platelets. 1989 Arch. Biochem. Biophys. pmid:2505676
Record M et al. Subcellular localization of phospholipids and enzymes involved in PAF-acether metabolism. 1989 J. Cell. Biochem. pmid:2506197
Ryan JP et al. Platelet activating factor (PAF) production by mouse embryos in vitro and its effect on embryonic metabolism. 1989 J. Cell. Biochem. pmid:2506198
Boughton-Smith NK et al. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. 1989 Prostaglandins pmid:2506613
Violi F et al. Inhibition of cyclooxygenase-independent platelet aggregation by sodium salicylate. 1989 Thromb. Res. pmid:2506658
Dembinska-Kiec A et al. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed. 1989 Prostaglandins pmid:2717778
Brunelleschi S et al. Interference of WEB 2086 and BN 52021 with Paf-induced effects on guinea-pig trachea. 1989 Br. J. Pharmacol. pmid:2758225
Sirén AL and Feuerstein G Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. 1989 Am. J. Physiol. pmid:2546449
Barzaghi G and Mong S Platelet activating factor-amidophosphonate (PAF-AP), a partial agonist inhibited platelet activating factor-induced calcium mobilization in human monocytic leukemic U-937 cell. 1989 Life Sci. pmid:2536882
Snyder F Biochemistry of platelet-activating factor: a unique class of biologically active phospholipids. 1989 Proc. Soc. Exp. Biol. Med. pmid:2536942
McColl SR et al. Involvement of guanine nucleotide binding proteins in neutrophil activation and priming by GM-CSF. 1989 Blood pmid:2537115
Barzaghi G et al. Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture. 1989 J. Pharmacol. Exp. Ther. pmid:2537401
Okubo K et al. The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques. 1989 Kurume Med J pmid:2700767
Dent G et al. Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086. Correlation between receptor binding and function. 1989 FEBS Lett. pmid:2537761
Johnson RA et al. An asymmetric synthesis of (R) and (S)-1-alkoxy-2,3-propanediols including precursors to platelet activating factor. 1989 Chem. Phys. Lipids pmid:2766428
Redkar-Brown DG and Aharony D Inhibition of antigen-induced contraction of guinea pig trachea by ICI 198,615. 1989 Eur. J. Pharmacol. pmid:2767127
Koenderman L and Bruijnzeel PL Increased sensitivity of the chemoattractant-induced chemiluminescence in eosinophils isolated from atopic individuals. 1989 Immunology pmid:2767711
Pitton C et al. Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis. 1989 J. Natl. Cancer Inst. pmid:2769781
Tolins JP et al. Role of platelet activating factor in endotoxemic acute renal failure in the male rat. 1989 J. Lab. Clin. Med. pmid:2538527
Burch RM and Tiffany CW Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin 1, bradykinin, and other agonists. 1989 J. Cell. Physiol. pmid:2550484
Pretolani M et al. Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs. 1989 J. Pharmacol. Exp. Ther. pmid:2464060
Goswami SK et al. Platelet-activating factor stimulates secretion of respiratory glycoconjugate from human airways in culture. 1989 J. Allergy Clin. Immunol. pmid:2478607
Harper MJ et al. Spermicidal effect of antagonists of platelet-activating factor. 1989 Fertil. Steril. pmid:2707465
Burstein SH et al. Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid. 1989 J. Pharmacol. Exp. Ther. pmid:2553925
Sawyer DB and Andersen OS Platelet-activating factor is a general membrane perturbant. 1989 Biochim. Biophys. Acta pmid:2480815
Mencia-Huerta JM et al. Effect of long-term administration of platelet-activating factor on pulmonary responsiveness and morphology in the guinea pig. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2707878
Bonavida B et al. Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2707879
Dorsch W et al. Antiasthmatic effects of onions. Prevention of platelet-activating factor induced bronchial hyperreactivity to histamine in guinea pigs by diphenylthiosulfinate. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2707885
Murphy TM et al. PAF-induced contraction of canine trachea mediated by 5-hydroxytryptamine in vivo. 1989 J. Appl. Physiol. pmid:2708195
Salem P et al. Presence of paf-acether in human thymus. 1989 FEBS Lett. pmid:2806565
Ricker DD et al. The effects of platelet-activating factor on the motility of human spermatozoa. 1989 Fertil. Steril. pmid:2806605
Guinot P et al. Tanakan inhibits platelet-activating-factor-induced platelet aggregation in healthy male volunteers. 1989 Haemostasis pmid:2807039
Weichert W and Breddin HK A PAF-acether antagonist (N 48740 RP/Rhône-Poulenc) and laser-induced thrombi in rat mesenteric vessels. 1989 Haemostasis pmid:2807041
Guarner F et al. Endotoxin-induced ascites formation in the rat: partial mediation by platelet-activating factor. 1989 Hepatology pmid:2807157
Kaminker AJ and Carreras LO [Physiopathology of thrombotic microangiopathy]. 1989 Sangre (Barc) pmid:2667170
Mizushima H et al. Purification of rabbit platelet secretory phospholipase A2 and its characteristics. 1989 J. Biochem. pmid:2668261
Harper MJ Platelet-activating factor: a paracrine factor in preimplantation stages of reproduction? 1989 Biol. Reprod. pmid:2669984
Page C and Abbott A PAF: new antagonists, new roles in disease and a major role in reproductive biology. 1989 Trends Pharmacol. Sci. pmid:2672467
Braquet P et al. The role of platelet-activating factor in cerebral ischemia and related disorders. 1989 Ann. N. Y. Acad. Sci. pmid:2672941
Badr KF et al. Glomerular responses to platelet-activating factor in the rat: role of thromboxane A2. 1989 Am. J. Physiol. pmid:2912165
Oh-ishi S et al. Pharmacological demonstration of inflammatory mediators using experimental inflammatory models: rat pleurisy induced by carrageenin and phorbol myristate acetate. 1989 Dermatologica pmid:2673856
Hong JL et al. [Effects of tetrandrine on cytoplasmic free calcium in rat neutrophils]. 1989 Zhongguo Yao Li Xue Bao pmid:2561935
Filep J et al. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog. 1989 Biochem. Biophys. Res. Commun. pmid:2916986
Tilley JW et al. Biphenylcarboxamide derivatives as antagonists of platelet-activating factor. 1989 J. Med. Chem. pmid:2754708
Camoratto AM and Grandison L Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro. 1989 Endocrinology pmid:2917522
Guthrie RW et al. Pentadienyl carboxamide derivatives as antagonists of platelet-activating factor. 1989 J. Med. Chem. pmid:2754709
Esplugues JV and Whittle BJ Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats. 1989 Am. J. Physiol. pmid:2919672
Oda M et al. [Platelet-activating factor producing cell--target cell interactions]. 1989 Rinsho Byori pmid:2754814
Adamus WS et al. Safety, tolerability, and pharmacologic activity of multiple doses of the new platelet activating factor antagonist WEB 2086 in human subjects. 1989 Clin. Pharmacol. Ther. pmid:2920502
Rogers DF et al. Plasma exudation. Correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo. 1989 J Pharmacol Methods pmid:2755146
Kroegel C et al. Characterization of platelet-activating factor-induced elevation of cytosolic free calcium concentration in eosinophils. 1989 FEBS Lett. pmid:2920824
Nolte D [Platelet activating factor produces platelet activating factor, comes to nothing]. 1989 Med. Klin. (Munich) pmid:2755413
Joseph R and Welch KM Granulocytes, platelet activating factor, and stroke. 1989 Stroke pmid:2756548
Pretolani M et al. From anti-asthma drugs to PAF-acether antagonism and back. Present status. 1989 Biochem. Pharmacol. pmid:2655601
Esplugues JV and Whittle BJ Gastric effects of PAF. 1989 Methods Find Exp Clin Pharmacol pmid:2657290
Makino S [Platelet-activating factor and disease]. 1989 Kokyu To Junkan pmid:2657915
Townley RG et al. Platelet-activating factor and airway reactivity. 1989 J. Allergy Clin. Immunol. pmid:2659646
Trebien HA and Calixto JB Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. 1989 Agents Actions pmid:2660497
Miadonna A et al. Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways. 1989 Am. Rev. Respir. Dis. pmid:2546468
Bruijnzeel PL et al. Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes. 1989 Drugs pmid:2547570
Spina D et al. The role of platelet activating factor in allergic inflammation. 1989 Pulm Pharmacol pmid:2520484
De Vos C et al. Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2523357
Hemmendinger S et al. Platelet function: aggregation by PAF or sequestration in lung is not modified during immediate or late allergen-induced bronchospasm in man. 1989 J. Allergy Clin. Immunol. pmid:2523922
Kaufman SE et al. Effects of human GM-CSF on neutrophil degranulation in vitro. 1989 Exp. Hematol. pmid:2502423
Marx MH et al. Darmstoff analogues. 3. Actions of choline esters of acetal phosphatidic acids on visceral smooth muscle. 1989 J. Med. Chem. pmid:2724301
Cucala M et al. CNS effects of platelet-activating factor on the rat stomach. 1989 Methods Find Exp Clin Pharmacol pmid:2725123
Schirmer WJ et al. Systemic and renal hemodynamic response to platelet activating factor. 1989 Prog. Clin. Biol. Res. pmid:2726980
Skvortsov AA et al. [New approaches to the study of thrombocyte aggregation in patients with dilated cardiomyopathy]. 1989 Ter. Arkh. pmid:2727928
Desquand S et al. Antigen-induced bronchopulmonary alterations in the guinea pig: a new model of passive sensitization mediated by mouse IgE antibodies. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2731996
Binnaka T et al. Gastric mucosal damage induced in rats by intravenous administration of platelet-activating factor. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595311
Hatakeyama K et al. Platelet activating factor induced gastric damage in rats: participation of increased gastric vascular permeability. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595312
García-Sáinz JA Intercellular communication within the liver has clinical implications. 1989 Trends Pharmacol. Sci. pmid:2595791
Koenderman L et al. 1,2-Diacylglycerol accumulation in human neutrophils does not correlate with respiratory burst activation. 1989 FEBS Lett. pmid:2597277
Hanglow AC et al. Effects of platelet-activating factor on ion transport in isolated rat jejunum. 1989 Am. J. Physiol. pmid:2597284
Omann GM et al. Oscillating actin polymerization/depolymerization responses in human polymorphonuclear leukocytes. 1989 J. Biol. Chem. pmid:2550438
Heidel JR et al. Characterization of arachidonic acid metabolism, superoxide production, and bacterial killing in bovine circulating neutrophils and elicited alveolar neutrophils. 1989 J. Leukoc. Biol. pmid:2543724
Chau LY et al. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes. 1989 Biochem. Biophys. Res. Commun. pmid:2545193
Thierry A et al. Presence of specific platelet-activating factor binding sites in the rat retina. 1989 Eur. J. Pharmacol. pmid:2545464
Marquis O et al. Evidence for the existence and ionic modulation of platelet-activating factor receptors mediating degranulatory responses in human polymorphonuclear leukocytes. 1989 J. Pharmacol. Exp. Ther. pmid:2545861
Braquet P et al. Effect of platelet-activating factor on platelets and vascular endothelium. 1989 Semin. Thromb. Hemost. pmid:2546255
Kraemer R and Mullane KM Neutrophils delay functional recovery of the post-hypoxic heart of the rabbit. 1989 J. Pharmacol. Exp. Ther. pmid:2553929
Ichikawa Y et al. [Effect of glycyrrhizin on the production of platelet-activating factor from rat peritoneal exudate cells]. 1989 Arerugi pmid:2783037